Related Experiment Video
Updated: May 23, 2025
16:16
Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
Published on: September 13, 2013
15.2K
Epitope-directed selection of GPCR nanobody ligands with evolvable function
Meredith A Skiba1, Clare Canavan1, Genevieve R Nemeth1
1Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
Summary
Researchers developed a new method to create nanobodies, a type of antibody fragment, that can target G protein-coupled receptors (GPCRs). These nanobodies show potential for developing new therapeutics for GPCRs like the angiotensin II type I receptor (AT1R).
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Molecular and Cellular Pharmacology
- Drug Discovery and Development
Background:
- Antibodies offer high selectivity for targeting G protein-coupled receptors (GPCRs), a crucial class of drug targets.
- However, the development of antibody-based ligands for GPCRs remains limited, hindering therapeutic applications.
Purpose of the Study:
- To develop a generalizable method for selecting nanobody ligands against GPCRs.
- To investigate the potential of nanobodies as modulators and inhibitors of the angiotensin II type I receptor (AT1R).
Main Methods:
- Utilized a synthetic camelid antibody fragment (nanobody) library for selection of GPCR ligands.
- Employed structure-guided design to engineer nanobody allosteric modulators into competitive inhibitors.
- Focused on the angiotensin II type I receptor (AT1R) as a model GPCR target.
Main Results:
- Successfully identified multiple nanobody ligands specific for the angiotensin II type I receptor (AT1R).
- Demonstrated that nanobodies can function as allosteric modulators, exhibiting selectivity for the receptor and ligand chemical properties.
- Engineered two nanobodies into competitive AT1R inhibitors through targeted mutations.
Conclusions:
- Nanobodies are versatile scaffolds capable of encoding diverse pharmacological behaviors against GPCRs.
- The developed selection method is generalizable for discovering novel GPCR-targeting nanobodies.
- Engineered nanobodies hold significant promise for the development of next-generation GPCR therapeutics.
Related Concept Videos
02:53Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
01:12GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K